Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free TLSIW Stock Alerts

TriSalus Life Sciences (TLSIW) Competitors

TriSalus Life Sciences logo
$0.90 0.00 (0.00%)
Closing price 08/28/2026
Extended Trading
$0.92 +0.03 (+2.78%)
As of 03:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

TLSIW vs. DRTSW, BDMDW, COCHW, HSCSW, and BEATW

Should you buy TriSalus Life Sciences stock or one of its competitors? TriSalus Life Sciences's main competitors and comparable companies include Alpha Tau Medical (DRTSW), Baird Medical Investment (BDMDW), Envoy Medical (COCHW), Heart Test Laboratories (HSCSW), and HeartBeam (BEATW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does TriSalus Life Sciences compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and TriSalus Life Sciences (NASDAQ:TLSIW) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
TriSalus Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
TriSalus Life Sciences$45.08MN/AN/AN/AN/A

In the previous week, Alpha Tau Medical and Alpha Tau Medical both had 2 articles in the media. Alpha Tau Medical's average media sentiment score of 1.43 beat TriSalus Life Sciences' score of 0.44 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company Overall Sentiment
Alpha Tau Medical Positive
TriSalus Life Sciences Neutral

Summary

Alpha Tau Medical and TriSalus Life Sciences tied by winning 1 of the 2 factors compared between the two stocks.

How does TriSalus Life Sciences compare to Baird Medical Investment?

Baird Medical Investment (NASDAQ:BDMDW) and TriSalus Life Sciences (NASDAQ:TLSIW) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability.

In the previous week, TriSalus Life Sciences had 1 more articles in the media than Baird Medical Investment. MarketBeat recorded 2 mentions for TriSalus Life Sciences and 1 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 1.87 beat TriSalus Life Sciences' score of 0.44 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company Overall Sentiment
Baird Medical Investment Very Positive
TriSalus Life Sciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baird Medical Investment$22.54MN/AN/AN/AN/A
TriSalus Life Sciences$45.08MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Baird Medical InvestmentN/A N/A N/A
TriSalus Life Sciences N/A N/A N/A

Summary

TriSalus Life Sciences beats Baird Medical Investment on 2 of the 3 factors compared between the two stocks.

How does TriSalus Life Sciences compare to Envoy Medical?

TriSalus Life Sciences (NASDAQ:TLSIW) and Envoy Medical (NASDAQ:COCHW) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, risk and dividends.

In the previous week, TriSalus Life Sciences had 1 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for TriSalus Life Sciences and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.89 beat TriSalus Life Sciences' score of 0.44 indicating that Envoy Medical is being referred to more favorably in the news media.

Company Overall Sentiment
TriSalus Life Sciences Neutral
Envoy Medical Very Positive

Company Net Margins Return on Equity Return on Assets
TriSalus Life SciencesN/A N/A N/A
Envoy Medical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$45.08MN/AN/AN/AN/A
Envoy Medical$207KN/AN/AN/AN/A

Summary

TriSalus Life Sciences beats Envoy Medical on 2 of the 3 factors compared between the two stocks.

How does TriSalus Life Sciences compare to Heart Test Laboratories?

Heart Test Laboratories (NASDAQ:HSCSW) and TriSalus Life Sciences (NASDAQ:TLSIW) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.

In the previous week, TriSalus Life Sciences had 1 more articles in the media than Heart Test Laboratories. MarketBeat recorded 2 mentions for TriSalus Life Sciences and 1 mentions for Heart Test Laboratories. Heart Test Laboratories' average media sentiment score of 1.87 beat TriSalus Life Sciences' score of 0.44 indicating that Heart Test Laboratories is being referred to more favorably in the media.

Company Overall Sentiment
Heart Test Laboratories Very Positive
TriSalus Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
Heart Test LaboratoriesN/A N/A N/A
TriSalus Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heart Test Laboratories$4.32KN/AN/AN/AN/A
TriSalus Life Sciences$45.08MN/AN/AN/AN/A

Summary

TriSalus Life Sciences beats Heart Test Laboratories on 2 of the 3 factors compared between the two stocks.

How does TriSalus Life Sciences compare to HeartBeam?

TriSalus Life Sciences (NASDAQ:TLSIW) and HeartBeam (NASDAQ:BEATW) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$45.08MN/AN/AN/AN/A
HeartBeamN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
TriSalus Life SciencesN/A N/A N/A
HeartBeam N/A N/A N/A

In the previous week, TriSalus Life Sciences had 1 more articles in the media than HeartBeam. MarketBeat recorded 2 mentions for TriSalus Life Sciences and 1 mentions for HeartBeam. HeartBeam's average media sentiment score of 1.87 beat TriSalus Life Sciences' score of 0.44 indicating that HeartBeam is being referred to more favorably in the news media.

Company Overall Sentiment
TriSalus Life Sciences Neutral
HeartBeam Very Positive

Summary

TriSalus Life Sciences beats HeartBeam on 2 of the 3 factors compared between the two stocks.

Get TriSalus Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLSIW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLSIW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLSIW vs. The Competition

Export
MetricTriSalus Life SciencesHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$5.78B$7.18B$12.88B
Dividend YieldN/A1.75%2.54%11.27%
P/E RatioN/A25.92273.1725.45
Price / SalesN/A78.68637.96103.59
Price / CashN/A33.6928.7436.03
Price / BookN/A6.1811.086.36
Net IncomeN/A$149.94M$3.48B$349.79M
7 Day Performance-21.05%-0.70%0.21%-0.48%
1 Month Performance16.88%5.99%7.75%4.17%
1 Year Performance-51.61%6.19%24.68%15.11%

TriSalus Life Sciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLSIW
TriSalus Life Sciences
N/A$0.90
flat		N/AN/A$0.00$45.08MN/A106
DRTSW
Alpha Tau Medical
N/A$4.00
-2.4%		N/A+1,346.6%$0.00N/AN/A80
BDMDW
Baird Medical Investment
N/A$0.04
+1.8%		N/A-48.6%$0.00$22.54MN/AN/A
COCHW
Envoy Medical
N/A$0.04
+29.6%		N/AN/A$0.00$207KN/A34
HSCSW
Heart Test Laboratories
N/A$0.04
-19.7%		N/A-32.9%$0.00$4.32KN/A10

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:TLSIW) was last updated on 8/31/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel